Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  

Premier Sponsors:  

Beckman Coulter Life Sciences 

Boston Healthcare


Charles River Discovery




Silicon Biosystems   




  View All Sponsors 

Cambridge Healthtech Institute’s 2nd Annual

Precision Medicine

Beyond the Genome for Insights into New Treatments

February 20-22, 2017  | Moscone North Convention Center | San Francisco, CA
Part of the 24th International Molecular Medicine Tri-Conference


The Precision Medicine meeting will outline the steps needed to personalize therapy and make it available to patients and physicians. This year’s exciting agenda will take a comprehensive look at the construction of gene panels, the use of molecular assays for selecting patients for treatments including but not limited to immunotherapy, the computational tools that allow sharing of data amongst institutions and enable improved medical decision making and patient outcomes. Leaders of the community will convene to talk about how precision medicine is transforming the field of medicine, accelerating biomedical discoveries and enabling the accurate diagnosis and treatment of disease.

Who should attend: Chief Strategy Officer, CEO, CMO, COO, CSO, CTO, Director, Lab Head, Manager, President, Professor, Research Scientist, VP from Genomics, Diagnostics, Applied Technology, Oncology, Genomic Targets

Topics will include, but are not limited to:

  • Review of how physicians are using precision medicine in oncology, infectious disease, microbiology, cardiology, diabetes
  • IT infrastructure needed for precision medicine
  • Education and training of pathologists in precision medicine
  • Precision medicine implementation strategies
  • Calculating overall risk of treatment
  • Precision medicine approach to activating the immune system
  • Companion diagnostics tailored to immunotherapy
  • Developing standards for analysis, interpretation and reporting of clinical genome sequencing results
  • Sharing patient data to achieve statistical power
  • "Computational" pathology for precision medicine
  • Newborn testing and screening using whole genome sequencing

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for submission is July 25, 2016.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program.  Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:

For partnering and sponsorship information, please contact:

Christina Lingham
Executive Director, Conferences
Cambridge Healthtech Institute
T: (+1) 781-972-5464
E: clingham@healthtech.com

Jon Stroup (Companies A-K)
Senior Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com

Joseph Vacca (Companies L-Z) 
Director, Business Developmentt
Cambridge Healthtech Institute
T: (+1) 781-972-5431
E: jvacca@healthtech.com